- API
Any substance that is represented for use in a drug and that, when used in the manufacturing, processing, or packaging ...
- Active Ingredient
Any component that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, ...
- CAS No.
Unique number assigned to a specific chemical (identified by its chemical name) by the American Chemical Society and ...
Cytisine
Catalog No. | PI0042 |
---|---|
CAS No. | 485-35-8 |
Molecular Formula | C11H14N2O |
Molecular Weight | 190.24 |
Purity | 99% HPLC |
Package | 25 kg/drum |
Botanical Source | Thermopsis lanceolata |
Appearance | White powder to yellow powder |
Storage | Stored in cool and dry places, protected from direct sunlight and heat. |
Shelf Life | 2 years |
Note: This cytisine can also be used as reference standards. You can find it under the category of Reference Substance at Herbalext.com. |
Safety Tips of Cytisine
Handling of cytisine should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes.
Related Applications
Antineoplastic
Each year, more and more people are getting cancer, especially lung and liver cancer. However, there are not enough good anti-cancer drugs. Fortunately, many herbal extracts have good antineoplastic activity. A plant-based diet can help shield you from cancer because plants are rich in anti-inflammatory and antioxidant substances that help us withstand exposure to ultraviolet radiation, air pollution and other noxious substances.
Related Researches
- 1. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
Sala M, et al. Br J Pharmacol 2013 Feb;168(4):835-49.
- 2. Cytisine confers neuronal protection against excitotoxic injury by down-regulating GluN2B-containing NMDA receptors.
Li YJ, et al. Neurotoxicology 2013 Jan;34:219-25.
- 3. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
Ni R, et al. J Alzheimers Dis 2013;33(3):841-51.
- 4. Nicotinic α4β2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹?F-fluoropropyl)pyridine (¹?F-Nifrolene) using PET.
Pichika R, et al. Nucl Med Biol 2013 Jan;40(1):117-25.
- 5. Molecular determinants of subtype-selective efficacies of cytisine and the novel compound NS3861 at heteromeric nicotinic acetylcholine receptors.
Harpsøe K, et al. J Biol Chem 2013 Jan 25;288(4):2559-70.
- 6. Study on noncovalent complexes of alkaloids with DNA duplex using electrospray ionization mass spectrometry.
Ma L, et al. Rapid Commun Mass Spectrom 2013 Jan 15;27(1):51-8.
- 7. Patterns of nicotinic receptor antagonism II: Cardiovascular effects in rats.
Jutkiewicz EM, et al. Drug Alcohol Depend 2013 Jan 17.
- 8. Nicotine-morphine interactions at α4β2, α7 and α3(?) nicotinic acetylcholine receptors.
Talka R, et al. Eur J Pharmacol 2013 Feb 15;701(1-3):57-64.
- 9. Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats.
Sotomayor-Zárate R, et al. Psychopharmacology (Berl) 2013 May;227(2):287-98.
- 10. Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis.
Hajek P, et al. Thorax 2013 Feb 12.